MLYS

Mineralys Therapeutics, Inc.

• Simply Wall St·8h ago

  Is Mineralys Therapeutics (MLYS) Undervalued After New Phase 3 Lorundrostat Data?

• TipRanks·1d ago

  Mineralys Therapeutics presents new analysis from Launch-HTN trial

• Benzinga·1d ago

  Mineralys Therapeutics Reports New Data Of Analysis From Its Pivotal Phase 3 Launch-HTN Study

• Simply Wall St·10/04 06:15

  Will AHA Trial Data Change Mineralys Therapeutics (MLYS) Narrative

• Benzinga·10/01 20:06

  Mineralys Therapeutics To Present Five Abstracts At American Heart Association Hypertension Scientific Sessions 2026,

• Simply Wall St·09/26 08:24

  Mineralys Therapeutics (MLYS) In Focus As Lorundrostat Data Nears Fair Value Debate

• Simply Wall St·09/24 21:31

  How Investors Are Reacting To Mineralys Therapeutics (MLYS) Long Term Blood Pressure Data

• Benzinga·09/23 20:07

  Mineralys Therapeutics To Present New Long-Term Efficacy And Safety Data From Ongoing Transform-HTN Open-Label Extension Trial Of Aldosterone Synthase Inhibitor Lorundrostat At AHA Scientific Sessions 2026

• Seeking Alpha·09/03 20:25

  Mineralys: Why I'm Making Stock A Buy Ahead Of Hypertension Approval Decision

• Seeking Alpha·09/01 14:15

  Mid-cap healthcare stocks ranked by quant ratings after earnings season

• Seeking Alpha·08/27 23:09

  THQ Offers High-Yield Income From Healthcare Stocks (Rating Upgrade)

• Simply Wall St·08/22 16:24

  Why Mineralys Therapeutics (MLYS) Is Getting Fresh Attention

• Simply Wall St·08/19 09:16

  Does New CMO Hire and Heavier Leverage Reshape the Bull Case For Mineralys Therapeutics (MLYS)?

• TipRanks·08/17 09:23

  Mineralys Therapeutics price target lowered to $49 from $51 at BofA

• TipRanks·08/13 11:10

  Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)